What is NDC 50090-7787?

50090-7787 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 2 package NDCs, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Triazolam?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Triazolam NDC 50090-7787 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-7787Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-7787Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-7787-0	50090778700	30 TABLET in 1 BOTTLE (50090-7787-0)Marketed from Nov 24, 2025
50090-7787-1	50090778701	100 TABLET in 1 BOTTLE (50090-7787-1)Marketed from Nov 24, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triazolam
Generic name (nonproprietary): triazolam
Active ingredients: Triazolam — .25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213003
Marketing start: Dec 30, 2022
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 50090-7787_06d8619e-5eaf-482f-b7bc-d2b44c8be8baSPL ID 06d8619e-5eaf-482f-b7bc-d2b44c8be8baSPL set ID 0a96c618-1869-4cb6-b9f3-549e8581af72RxCUI 198318UNII 1HM943223R
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090778700 followed by a unit qualifier and the quantity

Package 50090-7787-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam tablets are a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-7787

What is NDC 50090-7787?: 50090-7787 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Triazolam.
What is the active ingredient?: Triazolam.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Triazolam?: 13 other product NDCs are listed under this name. See all Triazolam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Triazolam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1289	70710-1289-0170710-1289-0570710-1289-08
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1521	70710-1521-0170710-1521-0570710-1521-08
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1162	70771-1162-0170771-1162-0570771-1162-08
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1576	70771-1576-0170771-1576-0570771-1576-08
Triazolam	Triazolam .25 mg/1	TabletOral	A-S Medication Solutions	50090-6471	50090-6471-0050090-6471-01
Triazolam	Triazolam .125 mg/1	TabletOral	Ingenus Pharmaceuticals, LLC	50742-645	50742-0645-01
Triazolam	Triazolam .25 mg/1	TabletOral	Ingenus Pharmaceuticals, LLC	50742-646	50742-0646-0150742-0646-05
Triazolam	Triazolam .25 mg/1	TabletOral	Bryant Ranch Prepack	71335-1876	71335-1876-0071335-1876-0171335-1876-02+7 more
Triazolam	Triazolam .25 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-349	72789-0349-30
Triazolam	Triazolam .25 mg/1	TabletOral	Proficient Rx LP	82804-275	82804-0275-30

All 14 Triazolam NDCs

Other NDCs under ANDA 213003

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213003
Product	Strength	Form · route	Labeler	Product NDC
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1289
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1521
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1162
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1576